PHAT - Phathom Pharmaceuticals, Inc.

QQQ $ 629.58 $ -2.30 (-0.36 %)

DIA $ 477.39 $ 3.24 (0.68 %)

SPY $ 683.22 $ -0.60 (-0.09 %)

TLT $ 90.46 $ 0.06 (0.07 %)

GLD $ 368.54 $ 3.45 (0.94 %)

Previous Close

$ 13.53

Open

$ 13.89

Bid

$ 13.81 x 10

Ask

$ 13.98 x 300

Day's Range

$ 13.64 - $ 16.06

52 Week Range

$ 2.21 - $ 19.50

Volume

942,969

Average Volume

Market Cap

962.5M

Beta (5Y Monthly)

$ 1.44

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-30-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-01-2025	03-31-2025	10-Q
4	03-06-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	03-07-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-10-2023	06-30-2023	10-Q
11	05-10-2023	03-31-2023	10-Q
12	02-28-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-02-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	03-01-2022	12-31-2021	10-K
17	11-08-2021	09-30-2021	10-Q
18	08-10-2021	06-30-2021	10-Q
19	05-11-2021	03-31-2021	10-Q
20	03-30-2021	12-31-2020	10-K
21	11-10-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-12-2020	03-31-2020	10-Q
24	03-19-2020	12-31-2019	10-K
25	11-25-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Phathom Pharmaceuticals Raises FY2025 Sale...
10/30/2025 11:24:54

Phathom Pharmaceuticals (NASDAQ:PHAT) raises FY2025 sales outlook from $165.000 million-$175.000 million to $170.000 million-$1...

Phathom Pharmaceuticals Q3 Adj. EPS $(0.15...
10/30/2025 11:21:20

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate ...

Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

Reported Saturday, Phathom Pharmaceuticals...
10/27/2025 06:57:23

Data published in the American Journal of Gastroenterology showed rapid and sustained relief of nighttime gastroesophageal refl...

Phathom Pharmaceuticals To Highlight Gast...
10/23/2025 12:14:04

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and commercializing novel treatm...

Phathom Pharmaceuticals Appoints Sanjeev N...
10/06/2025 12:11:49

Sanjeev Narula brings proven success in scaling commercial-stage biopharma companies with expertise in capital and investor str...

12 Health Care Stocks Moving In Wednesday'...
10/01/2025 21:05:58

Phathom Pharmaceuticals Clarifies That Sch...
08/20/2025 12:07:02

Phathom Pharmaceuticals Sees FY2025 Sales ...
08/07/2025 13:48:12

Phathom Pharmaceuticals (NASDAQ:PHAT) sees FY2025 sales of $165.000 million-$175.000 million vs $159.818 million analyst estimate.

Phathom Pharmaceuticals Q2 Adj. EPS $(0.79...
08/07/2025 11:01:21

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate ...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Phathom Pharmaceuticals Announces FDA Upda...
06/16/2025 12:08:34

unusual-machines-celldex-therapeutics-rh-and-other-big-stocks-moving-higher-on-friday

Unusual Machines, Celldex Therapeutics, RH...
06/13/2025 14:11:27

Craig-Hallum Maintains Buy on Phathom Phar...
06/09/2025 14:47:23

Craig-Hallum analyst Chase Knickerbocker maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and raises the price tar...

HC Wainwright & Co. Reiterates Buy on Phat...
06/09/2025 11:27:12

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

phathom-pharmaceuticals-stock-doubles-after-fda-grants-full-10-year-exclusivity-for-voquezna

Phathom Pharmaceuticals Stock Doubles Afte...
06/06/2025 19:24:24

Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) shares are trading lower Friday after the company announced a major regulatory win.

Needham Maintains Buy on Phathom Pharmaceu...
06/06/2025 18:44:36

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $28 price target.

12 Health Care Stocks Moving In Friday's I...
06/06/2025 17:06:47

Phathom Pharmaceuticals Shares Resume Trading
06/06/2025 16:29:51

Phathom Pharmaceuticals Shares Halted On C...
06/06/2025 16:24:57